Goodwin advised Mariana Oncology on the fundraising. Mariana Oncology Inc. announced its oversubscribed $175 million Series B financing co-led by Deep Track Capital and Forbion, and...
Mariana Oncology’s $175 Million Series B Financing Round
Revolution Medicines’ Acquisition of EQRx
Latham & Watkins advises Revolution Medicines on the deal, and Goodwin Procter advises EQRx. Revolution Medicines, Inc. (Nasdaq: RVMD) and EQRx, Inc. (Nasdaq: EQRX) announced a definitive agreement...